Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Met-Pro Study: The Role of METhanogens in the PROgression Of Parkinson's Disease and Related Neurological Conditions

NCT07786116 is registered in ClinicalTrials.gov with University of Cambridge as lead sponsor.

NCT NCT07786116
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07786116 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Met-Pro Study: The Role of METhanogens in the PROgression Of Parkinson's Disease and Related Neurological Conditions
Lead sponsor
University of Cambridge
Phase
Not applicable
Overall status
Recruiting
Start date
November 1, 2025
Completion date
March 31, 2028
Enrollment
215 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer dementia, alzheimer dementia (ad), alzheimer disease, alzheimer disease (ad), alzheimer s disease, constipation, dementia, dementia (diagnosis), dementia alzheimers, dementia mci (mild cognitive impairment), mild cognitive impairment, mild cognitive impairment (mci), mild cognitive impairment (mci) due to alzheimer's disease, parkinson, parkinson disease, parkinson disease (disorder), parkinson s disease, rem behavior disorder, rem sleep behavior disorder, rem sleep behavior disorder (irbd), rem sleep behaviour disorder, sibo